Chronic Pain in Women: New Study Reveals Why It Lasts Longer in Females

Unveiling the Science: How Immune Cells Drive Sex Differences in Pain Duration

A groundbreaking study published on February 20, 2026, in Science Immunology has finally pinpointed a key biological reason why chronic pain lasts longer in women compared to men. 90 86 Researchers from Michigan State University (MSU), led by Geoffroy Laumet, PhD, discovered that specialized immune cells known as interleukin-10-producing monocytes (IL-10+ monocytes) play a pivotal role in resolving pain signals. These monocytes communicate directly with pain-sensing neurons via the IL-10 receptor (IL-10R1), dampening neuronal excitability and promoting recovery. 88

In mouse models of inflammatory pain and traumatic injury—mimicking real-world scenarios like surgery or accidents—male mice exhibited faster pain resolution. This was linked to higher numbers of IL-10+ monocytes in their inflamed tissues. Females showed prolonged hypersensitivity, correlating with fewer of these pain-resolving cells. The study used advanced spectral flow cytometry to profile immune cells, revealing that a specific subset, CD206-high monocytes, is the primary IL-10 source. 90

Human data from the AURORA cohort of 245 trauma survivors further validated these findings. Men reported lower pain severity at 56 and 84 days post-injury, associated with elevated circulating monocytes and IL-10 levels. Statistical mediation analysis confirmed IL-10's role in linking monocyte counts to faster recovery. 90

Hormonal Influences: The Role of Testosterone and Estrogen

The sex disparity boils down to hormone-regulated immune responses. Androgens, particularly testosterone, enhance IL-10 production in monocytes via androgen receptors (AR). Experiments showed that treating female mice with dihydrotestosterone (DHT) increased IL-10+ monocytes and accelerated pain resolution, while castrating males or blocking AR with flutamide delayed it. 90 Estrogen in females appears to suppress this pathway, resulting in fewer pain-suppressing immune cells.

This mechanism challenges outdated notions that women's pain complaints are psychological. As Laumet noted, "The difference in pain between men and women has a biological basis. It's not in your head." 86 Understanding these pathways opens doors to targeted therapies, such as androgen agonists or topical testosterone, potentially offering non-opioid alternatives for chronic pain management.

Chronic Pain Burden in India: Stark Gender Disparities

In India, chronic pain—defined as persistent pain lasting over three months—affects 19-25% of adults, translating to 180-200 million people. 89 87 Women bear a disproportionate load, with prevalence at 25.2% versus 12.3% in men, making females 70.6% of sufferers. Pain is more frequent, intense, and enduring among women, often in the knees (23.6% in elderly), lower back, and head.89

Rural women face additional barriers, with higher untreated pain due to limited access to analgesics or specialists. Only 4.8% consult pain experts, despite 36% unable to perform daily tasks. 89 Recent 2025 data shows nearly 47% of those over 45 report joint pain, underscoring a public health crisis. 113

Mechanisms Step-by-Step: From Injury to Resolution

1. Injury Phase: Trauma triggers inflammation, activating monocytes that migrate to the site.
2. Monocyte Activation: In males, testosterone boosts AR signaling, increasing IL-10 production in CD206-high monocytes.
3. Signaling to Neurons: IL-10 binds IL-10R1 on sensory neurons, upregulating antinociceptive proteins and suppressing proinflammatory cytokines like IL-6, TNF.
4. Resolution: Neuronal hyperactivity quiets; pain fades. In females, fewer IL-10+ monocytes prolong this.
5. Therapeutic Boost: Resolvin D1 (RvD1), a pro-resolving lipid, enhances monocyte IL-10, equalizing resolution across sexes. 90

This active immune-neural crosstalk explains why chronic pain transitions occur more readily in women globally and in India. 88

Implications for Indian Women: Cultural and Healthcare Challenges

Indian women often endure pain silently due to cultural norms, exacerbating risks. Musculoskeletal pain dominates, linked to occupational strains in rural areas and lifestyle in urban settings. Fibromyalgia prevalence is 6.17% among western Indian women aged 18-60, with social factors worsening outcomes. 42 The MSU findings validate these experiences biologically, urging gender-sensitive care.

Experts emphasize timely intervention; delayed treatment heightens chronicity risks. For more on pain management careers, check research jobs in India's medical institutions.

Photo by Bloom IVF Centre Lucknow on Unsplash

Promising Therapies: Boosting IL-10 and Beyond

Resolvin D1 shows therapeutic promise, accelerating resolution without suppressing inflammation. 101 Prior research confirms resolvins alleviate neuropathic and inflammatory pain. 104 Testosterone therapy trials in women with fibromyalgia report pain relief, though larger studies are needed. 122 Non-opioid options are critical amid India's opioid access issues.

Read the full MSU study for detailed mechanisms.

Indian Universities Stepping Up: Research and Conferences

Institutions like AIIMS, PGIMER Chandigarh, and NIMHANS Bangalore lead pain research, though sex-specific studies lag. Upcoming events include ISSPCON 2026 and ICRA Pain 2026 in Kolkata, fostering advancements. 76 Indian Society for Study of Pain (ISSP) promotes education; more funding could address women's chronic pain. 141

Explore professor jobs or faculty positions in neurology and pain medicine at top Indian universities.

Stakeholder Perspectives: From Patients to Policymakers

• Patients: Validation reduces stigma; empowers seeking specialized care.
• Healthcare Providers: Train on sex differences; integrate IL-10 biomarkers.
• Researchers: Prioritize India-specific trials; collaborate globally.
• Government: Boost R&D via IndiaAI Mission; fund women's health studies.

Balanced views highlight evolutionary benefits—males' robust innate immunity—while addressing modern needs.

Future Outlook: Preventing Chronic Pain Transitions

By targeting monocytes early post-injury, chronic pain incidence could drop, especially among India's aging women. Longitudinal studies in diverse populations, including Indian cohorts, are essential. Actionable insights: Monitor monocyte/IL-10 post-trauma; trial RvD1 or AR modulators.

Professionals interested in this field can find research assistant jobs or career advice.

Career Opportunities in Pain Research Across India

With rising demand, Indian universities seek experts. India higher ed jobs include postdocs at IITs, faculty at AIIMS. Platforms like Rate My Professor aid networking. Conferences offer visibility for emerging scholars.

India's NEP 2020 emphasizes interdisciplinary research; pain science aligns perfectly. Visit postdoc opportunities or university jobs for openings.

Photo by Bhupathi Srinu on Unsplash

Key Takeaways and Call to Action

This MSU discovery revolutionizes understanding of chronic pain in women, with profound implications for India. Enhanced research at institutions like PGIMER can drive solutions. Aspiring academics, explore higher ed jobs, rate your professors, and career advice to join this vital field. Share experiences via comments below.